Rhea-AI Summary
Odyssey Therapeutics, Inc. insider Jolie Siegel reported existing derivative holdings on a Form 3. The filing shows a stock option to buy common stock with an exercise price of $5.15 per share for 78,958 underlying shares, expiring on March 11, 2036. According to the vesting terms, 25% of this option will vest on January 12, 2027, with the rest vesting in 36 equal monthly installments, contingent on continued service.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Odyssey Therapeutics (ODTX) SEC filings are available on StockTitan?
StockTitan tracks 11 SEC filings for Odyssey Therapeutics (ODTX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Odyssey Therapeutics (ODTX)?
The most recent SEC filing for Odyssey Therapeutics (ODTX) was filed on May 8, 2026.